Vascular Behçet syndrome: from pathogenesis to treatment

[1]  H. Direskeneli,et al.  Pulmonary arterial wall thickness is increased in Behçet's disease patients with major organ ınvolvement: Is it a sign of severity? , 2022, Rheumatology.

[2]  J. Karakaya,et al.  A new tool supporting the diagnosis of childhood-onset Behçet's disease: venous wall thickness. , 2022, Rheumatology.

[3]  A. Ishizu,et al.  Presence of neutrophil extracellular traps in superficial venous thrombosis of Behçet’s disease , 2022, The Journal of dermatology.

[4]  P. Demelo-Rodríguez,et al.  Arterial and venous involvement in Behçet’s syndrome: a narrative review , 2022, Journal of Thrombosis and Thrombolysis.

[5]  P. Cacoub,et al.  Vascular Behçet's disease: a comparative study from Turkey and France. , 2021, Clinical and experimental rheumatology.

[6]  W. Fu,et al.  Long-term outcomes of endovascular treatment for aortic pseudoaneurysm in patients with Behçet’s disease , 2021, Vascular.

[7]  A. Arcangeli,et al.  A unique circulating miRNA profile highlights thrombo-inflammation in Behçet’s syndrome , 2021, Annals of the Rheumatic Diseases.

[8]  Yin Su,et al.  Efficacy and safety of tocilizumab in Behçet’s syndrome with refractory arterial lesions: a single-centre observational cohort study in China , 2021, Rheumatology.

[9]  D. Attia.  Behçet's disease phenotypes and clinical outcomes: A cohort study in egyptian patients. , 2021, Reumatologia clinica.

[10]  H. Direskeneli,et al.  Pathogenesis of Behçet's Syndrome: Genetic, Environmental and Immunological Factors , 2021, Frontiers in Medicine.

[11]  A. Arcangeli,et al.  Circulating miRNome profiling data in Behçet's syndrome , 2021, Data in brief.

[12]  N. Taddei,et al.  Neutrophil‐mediated mechanisms of damage and in‐vitro protective effect of colchicine in non‐vascular Behçet’s syndrome , 2021, Clinical and experimental immunology.

[13]  H. Özer,et al.  Diagnostic Performance of Lower Extremity Venous Wall Thickness and Laboratory Findings in the Diagnosis of the Behçet Disease , 2021, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[14]  A. Ateş,et al.  Analysis of vascular involvement in 460 patients with Behçet's syndrome: Clinical characteristics and associated factors. , 2021, Joint bone spine.

[15]  A. Erden,et al.  Budd–Chiari syndrome in Behçet’s disease: a retrospective multicenter study , 2021, Clinical Rheumatology.

[16]  A. Soliman,et al.  Vasculitis damage index in Behçet’s disease , 2021, Advances in Rheumatology.

[17]  S. Ohno,et al.  Treatment of Behçet's Disease: An Algorithmic Multidisciplinary Approach , 2021, Frontiers in Medicine.

[18]  Y. Waheed,et al.  Possible Role of Regulatory B Cells in Different Behçet’s Disease Phenotypes and Therapies: First Report from Egypt , 2021, Journal of inflammation research.

[19]  A. Erden,et al.  Predictors for the Risk and Severity of Post Thrombotic Syndrome in Vascular Behcet's Disease. , 2021, Journal of vascular surgery. Venous and lymphatic disorders.

[20]  L. Biard,et al.  Direct oral anticoagulant for venous thrombosis in Behçet's syndrome. , 2021, Autoimmunity reviews.

[21]  A. Kasaeian,et al.  Diagnosis of Behçet’s disease: clinical characteristics, diagnostic criteria, and differential diagnoses , 2021, BMC Rheumatology.

[22]  V. Çobankara,et al.  Ultrasonographic measurement of the vascular wall thickness and intima-media thickness in patients with Behçet’s disease with symptoms or signs of vascular involvement: A cross-sectional study , 2021, Archives of rheumatology.

[23]  J. Guan,et al.  Characteristics and phenotype heterogeneity in late-onset Behçet’s syndrome: a cohort from a referral center in China , 2020, Clinical Rheumatology.

[24]  OUP accepted manuscript , 2021, Rheumatology.

[25]  Xin Yu,et al.  Neutrophil Extracellular Traps Promote Aberrant Macrophages Activation in Behçet’s Disease , 2021, Frontiers in Immunology.

[26]  Jiali Chen,et al.  Correspondence on ‘Critical role of neutrophil extracellular traps (NETs) in patients with Behcet’s disease’ , 2020, Annals of the Rheumatic Diseases.

[27]  P. Tugwell,et al.  Core Set of Domains for Outcome Measures in Behçet's Syndrome , 2020, Arthritis care & research.

[28]  F. Sofi,et al.  Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome. , 2020, Circulation research.

[29]  D. Isenberg,et al.  Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management , 2020, Thrombosis Research.

[30]  H. Direskeneli,et al.  Femoral Vein Wall Thickness Measurement May Be a Distinctive Diagnostic Tool to Differentiate Behçet’s Disease with Intestinal Involvement and Crohn’s Disease , 2020, Digestive Diseases and Sciences.

[31]  T. Ergun,et al.  Femoral vein wall thickness measurement: A new diagnostic tool for Behçet's disease. , 2020, Rheumatology.

[32]  D. Attia.  Behçet's Disease Phenotypes and Clinical Outcomes: A Cohort Study in Egyptian Patients. , 2020, Reumatologia clinica.

[33]  C. Lee,et al.  Surgical experience of Behcet's disease involving the peripheral artery. , 2020, Annals of vascular surgery.

[34]  Fengchun Zhang,et al.  A pilot study of tofacitinib for refractory Behçet’s syndrome , 2020, Annals of the Rheumatic Diseases.

[35]  G. Emmi,et al.  Behçet: the syndrome. , 2020, Rheumatology.

[36]  P. Demelo-Rodríguez,et al.  Chronic Budd–Chiari syndrome in Behçet's disease successfully managed with transjugular intrahepatic portosystemic shunt: a case report and literature review , 2020, Clinical Journal of Gastroenterology.

[37]  T. Ergun,et al.  Efficacy of TNFα inhibitors for refractory vascular Behçet's disease: A multicenter observational study of 27 patients and a review of the literature , 2020, International journal of rheumatic diseases.

[38]  Md. Asiful Islam,et al.  Prevalence of antiphospholipid antibodies in Behçet's disease: A systematic review and meta-analysis , 2020, PloS one.

[39]  S. Turroni,et al.  Modulation of gut microbiota through nutritional interventions in Behçet’s syndrome patients (the MAMBA study): study protocol for a randomized controlled trial , 2019, Trials.

[40]  L. Chiche,et al.  Factors influencing the recurrence of arterial involvement after surgical repair in Behçet disease. , 2019, Journal of Vascular Surgery.

[41]  G. Hatemi,et al.  Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome. , 2020, Rheumatology.

[42]  Yining Wang,et al.  The Clinical Features, Risk Factors, and Outcome of Aneurysmal Lesions in Behcet's Disease , 2019, Journal of immunology research.

[43]  N. Taddei,et al.  Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress , 2019, Front. Immunol..

[44]  G. Hatemi,et al.  Treating the Different Phenotypes of Behçet's Syndrome , 2019, Front. Immunol..

[45]  M. Kizilay,et al.  Coronary Involvement in Behçet's Disease: what are its Risks and Prognosis? (Rare Cases and Literature Review) , 2019, Brazilian journal of cardiovascular surgery.

[46]  H. Ebada,et al.  Characteristics and outcome of primary Budd-Chiari syndrome due to Behçet's syndrome. , 2019, Clinics and research in hepatology and gastroenterology.

[47]  H. Yazici,et al.  Increased frequency of obstructive sleep apnea syndrome in Behçet's syndrome patients with superior vena cava syndrome. , 2019, Clinical and experimental rheumatology.

[48]  E. S. Durmaz,et al.  Increased vein wall thickness in Behçet disease. , 2019, Journal of vascular surgery. Venous and lymphatic disorders.

[49]  Xiao-juan Guo,et al.  Multiple cardiovascular involvements in Behçet’s disease: unique utility of 18F-FDG PET/CT in diagnosis and follow-up , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[50]  A. Cazes,et al.  Critical role of neutrophil extracellular traps (NETs) in patients with Behcet’s disease , 2019, Annals of the rheumatic diseases.

[51]  G. Hatemi,et al.  Behçet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils , 2019, Front. Immunol..

[52]  J. Guan,et al.  Demography of vascular Behcet’s disease with different gender and age: an investigation with 166 Chinese patients , 2019, Orphanet Journal of Rare Diseases.

[53]  N. Taddei,et al.  Behçet’s syndrome as a tool to dissect the mechanisms of thrombo‐inflammation: clinical and pathogenetic aspects , 2018, Clinical and experimental immunology.

[54]  T. Ergun,et al.  Venous vessel wall thickness in lower extremity is increased in male patients with Behcet’s disease , 2019, Clinical Rheumatology.

[55]  E. Seyahi.  Phenotypes in Behçet’s syndrome , 2019, Internal and Emergency Medicine.

[56]  H. Yazici,et al.  Assessment of deep venous thrombosis in the lower extremity in Behçet’s syndrome: MR venography versus Doppler ultrasonography , 2019, Internal and Emergency Medicine.

[57]  E. Silvestri,et al.  Behçet's disease as a cause of cerebral sinus vein thrombosis: an emerging role. , 2018, Rheumatology.

[58]  B. Zeydan,et al.  Behçet’s disease as a causative factor of cerebral venous sinus thrombosis: subgroup analysis of data from the VENOST study , 2018, Rheumatology.

[59]  J. Mao,et al.  Local infiltration with cocktail analgesics during 2 level lumbar spinal fusion surgery , 2019, Medicine.

[60]  L. Biard,et al.  Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients. , 2018, Clinical immunology.

[61]  E. Silvestri,et al.  Vascular Behçet’s syndrome: an update , 2018, Internal and Emergency Medicine.

[62]  D. Nassar,et al.  Neutrophils contribute to vasculitis by increased release of neutrophil extracellular traps in Behçet's disease. , 2018, Journal of dermatological science.

[63]  V. Hamuryudan,et al.  Surgical Treatment of Pulmonary Complications in Behçet's Syndrome. , 2018, Seminars in thoracic and cardiovascular surgery.

[64]  R. Moots,et al.  Management of major organ involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations , 2018, Rheumatology.

[65]  P. Libby,et al.  Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1&agr; and Cathepsin G , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[66]  A. Vaglio,et al.  Adalimumab‐Based Treatment Versus Disease‐Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome , 2018, Arthritis & rheumatology.

[67]  C. Bal,et al.  Why are male patients with Behçet's disease prone to thrombosis? A rotational thromboelastographic analysis. , 2018, Clinical and experimental rheumatology.

[68]  A. Vaglio,et al.  Hemoptysis in Behçet’s syndrome: from bedside to bench? , 2018, Internal and Emergency Medicine.

[69]  Iman M Eissa,et al.  Vision-Threatening Behcet's Disease: Severity of Ocular Involvement Predictors , 2018, Journal of ophthalmology.

[70]  R. Moots,et al.  2018 update of the EULAR recommendations for the management of Behçet’s syndrome , 2018, Annals of the rheumatic diseases.

[71]  S. Hazen,et al.  Microbial modulation of cardiovascular disease , 2018, Nature Reviews Microbiology.

[72]  G. Hatemi,et al.  Behçet syndrome: a contemporary view , 2018, Nature Reviews Rheumatology.

[73]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[74]  Dennis Andersson,et al.  A retrospective cohort study , 2018 .

[75]  F. Davatchi,et al.  Imaging manifestations of Behcet's disease: Key considerations and major features. , 2018, European journal of radiology.

[76]  H. Direskeneli,et al.  Outcomes of Patients with Behçet's Syndrome after Pulmonary Endarterectomy , 2017, The Thoracic and Cardiovascular Surgeon.

[77]  B. Goksel,et al.  A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST Study. , 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[78]  M. Fafutis-Morris,et al.  Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview , 2017, Front. Immunol..

[79]  F. Shahram,et al.  Behcet’s disease: epidemiology, clinical manifestations, and diagnosis , 2017, Expert review of clinical immunology.

[80]  Wenjie Zheng,et al.  Cerebral venous sinus thrombosis in Behçet’s disease: a retrospective case-control study , 2017, Clinical Rheumatology.

[81]  M. Laffan,et al.  A low balance between microparticles expressing tissue factor pathway inhibitor and tissue factor is associated with thrombosis in Behçet’s Syndrome , 2016, Scientific Reports.

[82]  H. Yazici,et al.  Behçet syndrome: the vascular cluster. , 2016, Turkish journal of medical sciences.

[83]  B. Knebelmann,et al.  Case report and literature review , 2016, Medicine.

[84]  F. Numan,et al.  Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behçet's syndrome patients with pulmonary artery involvement during follow-up. , 2016, Clinical and experimental rheumatology.

[85]  T. Ergun,et al.  Post-thrombotic syndrome and venous disease-specific quality of life in patients with vascular Behçet's disease. , 2016, Journal of vascular surgery. Venous and lymphatic disorders.

[86]  E. Seyahi.  Behçet's disease: How to diagnose and treat vascular involvement. , 2016, Best practice & research. Clinical rheumatology.

[87]  S. Sangle,et al.  Pulmonary artery aneurysms in Behçet's disease treated with anti-TNFα: A case series and review of the literature. , 2016, Autoimmunity reviews.

[88]  S. Nishio,et al.  The responses of macrophages in interaction with neutrophils that undergo NETosis. , 2016, Journal of autoimmunity.

[89]  Rosanna Abbate,et al.  Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet Disease , 2016, Circulation.

[90]  H. Direskeneli,et al.  Dual effects of testosterone in Behcet's disease: implications for a role in disease pathogenesis , 2013, Genes and Immunity.

[91]  A. Stavropoulos,et al.  Retrospective case control study , 2016 .

[92]  G. Hatemi,et al.  Pulmonary artery involvement in Behçet׳s syndrome: Effects of anti-Tnf treatment. , 2015, Seminars in arthritis and rheumatism.

[93]  F. Nevens,et al.  Budd-Chiari syndrome , 2015, United European gastroenterology journal.

[94]  P. Merkel,et al.  Current Status, Goals, and Research Agenda for Outcome Measures Development in Behçet Syndrome: Report from OMERACT 2014 , 2015, The Journal of Rheumatology.

[95]  V. Oktay,et al.  Venous claudication in Behçet's disease. , 2015, Journal of vascular surgery.

[96]  V. Jiménez‐Yuste,et al.  Endothelial Dysfunction and Altered Coagulation As Mediators of Thromboembolism in Behçet Disease , 2015, Seminars in Thrombosis & Hemostasis.

[97]  N. Sut,et al.  Pulmonary artery aneurysms in Behçet's syndrome: a review of the literature with emphasis on geographical differences. , 2015, Clinical and experimental rheumatology.

[98]  H. Nasr,et al.  Superficial thrombophlebitis (superficial venous thrombosis) , 2015, BMJ : British Medical Journal.

[99]  A. Amedei,et al.  Microparticles: Bridging the Gap between Autoimmunity and Thrombosis , 2015, Seminars in Thrombosis & Hemostasis.

[100]  W. Krautgartner,et al.  The Role of Reactive Oxygen Species (ROS) in the Formation of Extracellular Traps (ETs) in Humans , 2015, Biomolecules.

[101]  Matteo Becatti,et al.  Thrombosis in vasculitis: from pathogenesis to treatment , 2015, Thrombosis Journal.

[102]  S. Rampelli,et al.  Behçet's syndrome patients exhibit specific microbiome signature. , 2015, Autoimmunity reviews.

[103]  E. Çağlar,et al.  An outcome survey of 43 patients with Budd-Chiari syndrome due to Behçet's syndrome followed up at a single, dedicated center. , 2015, Seminars in arthritis and rheumatism.

[104]  K. Dia,et al.  Superior vena cava syndrome revealing a Behçet’s disease , 2015, Thrombosis Journal.

[105]  F. Bonneville.  Imaging of cerebral venous thrombosis. , 2014, Diagnostic and interventional imaging.

[106]  N. Sut,et al.  Vascular involvement in Behçet's syndrome: a retrospective analysis of associations and the time course. , 2014, Rheumatology.

[107]  U. Kalyoncu,et al.  A rare but serious manifestation of Behçet's disease: intracardiac thrombus in 22 patients. , 2014, Clinical and experimental rheumatology.

[108]  D. Firmin,et al.  Magnetic resonance imaging of vein wall thickness in patients with Behçet's syndrome. , 2014, Clinical and experimental rheumatology.

[109]  G. Espinosa,et al.  Endogenous thrombin potential in Behçet's disease: relationship with thrombosis and anticoagulant therapy. , 2014, Clinical and experimental rheumatology.

[110]  A. Hamzaoui,et al.  Vena cava thrombosis in Behçet's disease. , 2014, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.

[111]  A. Pathare,et al.  Haemostatic Parameters in Patients with Behçet's Disease. , 2014, Sultan Qaboos University medical journal.

[112]  J. Piette,et al.  Ethnicity and association with disease manifestations and mortality in Behçet’s disease , 2014, Orphanet Journal of Rare Diseases.

[113]  D. Valla,et al.  Behcet’s disease in budd-chiari syndrome , 2013, Orphanet Journal of Rare Diseases.

[114]  T. Ergun,et al.  Evaluation of asymptomatic venous disease by venous Doppler ultrasonography in patients with Behcet's disease without overt thrombosis , 2014, Clinical Rheumatology.

[115]  T. Chinet,et al.  18F-fluorodeoxyglucose-positron emission tomography scanning is a useful tool for therapy evaluation of arterial aneurysm in Behçet's disease. , 2013, Joint, bone, spine : revue du rhumatisme.

[116]  H. Yazici,et al.  Fever in Behçet's syndrome. , 2013, Clinical and experimental rheumatology.

[117]  Xuemei Li,et al.  Major vascular involvement in Behçet’s disease: a retrospective study of 796 patients , 2013, Clinical Rheumatology.

[118]  K. Park,et al.  Peripheral arterial involvement in Behcet’s disease: an analysis of the results from a Korean referral center , 2013, Rheumatology International.

[119]  P. Marik,et al.  Narrative Review , 2012, Journal of intensive care medicine.

[120]  J. Piette,et al.  Immunosuppressants reduce venous thrombosis relapse in Behçet's disease. , 2012, Arthritis and rheumatism.

[121]  H. Yazıcı,et al.  Behçet Syndrome: Is It One Condition? , 2012, Clinical Reviews in Allergy & Immunology.

[122]  N. Sut,et al.  The papulopustular lesion/arthritis cluster of Behçet's syndrome also clusters in families. , 2012, Rheumatology.

[123]  Oliver Soehnlein,et al.  Multiple roles for neutrophils in atherosclerosis. , 2012, Circulation research.

[124]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[125]  R. Gershoni-baruch,et al.  Vascular behcet and mutations in thrombogenic genes: methylene tetrahydrofolate reductase, factor V, and prothrombin. , 2012, Genetic testing and molecular biomarkers.

[126]  G. Hatemi,et al.  Pulmonary Artery Involvement and Associated Lung Disease in Behçet Disease: A Series of 47 Patients , 2012, Medicine.

[127]  P. Cluzel,et al.  Long-Term Outcome of Arterial Lesions in Behçet Disease: A Series of 101 Patients , 2012, Medicine.

[128]  J. Piette,et al.  Spectrum of Cardiac Lesions in Behçet Disease: A Series of 52 Patients and Review of the Literature , 2012, Medicine.

[129]  H. Yazici,et al.  Management and prognosis of nonpulmonary large arterial disease in patients with Behçet disease. , 2012, Journal of vascular surgery.

[130]  S. Saip,et al.  Clinical characteristics of pediatric-onset neuro-Behçet disease , 2011, Neurology.

[131]  H. Yazici,et al.  The estimated pulmonary artery pressure can be elevated in Behçet's syndrome. , 2011, Respiratory medicine.

[132]  M. Macey,et al.  Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease. , 2011, Rheumatology.

[133]  A. Gyedu,et al.  Surgical treatment of peripheral aneurysms in patients with Behcet's disease. , 2011, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[134]  E. Onur,et al.  Oxidative stress impairs endothelial nitric oxide levels in Behçets’ disease , 2011, Cutaneous and ocular toxicology.

[135]  Y. Ishigatsubo,et al.  Characteristics of vascular involvement in Behçet's disease in Japan: a retrospective cohort study. , 2011, Clinical and experimental rheumatology.

[136]  Umair Khalid,et al.  Hughes-Stovin Syndrome , 2011, Orphanet journal of rare diseases.

[137]  Sung Bin Cho,et al.  Detection of cardiovascular system involvement in Behçet's disease using fluorodeoxyglucose positron emission tomography. , 2011, Seminars in arthritis and rheumatism.

[138]  S. Sungkanuparph,et al.  A CASE SERIES AND REVIEW OF THE LITERATURE , 2011 .

[139]  H. Erdem,et al.  Investigation of the veins in patients with Behçet’s disease with no known vascular event by Doppler ultrasonography , 2012, Rheumatology International.

[140]  A. Pathare,et al.  Pattern and outcome of vascular involvement of Omani patients with Behcet’s disease , 2011, Rheumatology International.

[141]  J. Ferro,et al.  Cerebral venous thrombosis in Behçet’s disease: a systematic review , 2011, Journal of Neurology.

[142]  F. Dentali,et al.  Homocysteine in Vascular Behçet Disease: A Meta-Analysis , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[143]  Z. Amoura,et al.  Mortality in Behçet's disease. , 2010, Arthritis and rheumatism.

[144]  W. Ruf,et al.  Neutrophils release brakes of coagulation , 2010, Nature Medicine.

[145]  G. Poli,et al.  A study on thrombophilic factors in Italian Behcet's patients. , 2010, Joint, bone, spine : revue du rhumatisme.

[146]  F. Shahram,et al.  Comparison of existing disease activity indices in the follow-up of patients with Behçet’s disease , 2009, Modern rheumatology.

[147]  P. Prandoni,et al.  Definition of post‐thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization , 2009, Journal of thrombosis and haemostasis : JTH.

[148]  D. Dormont,et al.  Cerebral venous thrombosis in Behçet's disease. , 2009, Arthritis and rheumatism.

[149]  N. Yesilot,et al.  Cerebral venous thrombosis in Behçet’s disease compared to those associated with other etiologies , 2009, Journal of Neurology.

[150]  A. Mert,et al.  Significance of serum interleukin‐8 levels in patients with Behcet's disease: high levels may indicate vascular involvement , 2009, International journal of dermatology.

[151]  R. Yeung,et al.  Matrix metalloproteinase 9 activity leads to elastin breakdown in an animal model of Kawasaki disease. , 2008, Arthritis and rheumatism.

[152]  Jae-Kwan Song,et al.  Cardiac Behçet Disease Presenting as Aortic Valvulitis/Aortitis or Right Heart Inflammatory Mass: A Clinicopathologic Study of 12 Cases , 2008, The American journal of surgical pathology.

[153]  H. Yazici,et al.  The Unique Features of Vasculitis in Behçet’s Syndrome , 2008, Clinical reviews in allergy & immunology.

[154]  F. Schmidt.  Meta-Analysis , 2008 .

[155]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[156]  A. Vayá,et al.  Platelet Activation and Red Blood Cell Phosphatidylserine Exposure Evaluated by Flow Cytometry in Patients with Behçet’s Disease: Are They Related to Thrombotic Events? , 2008, Pathophysiology of Haemostasis and Thrombosis.

[157]  E. Koh,et al.  Treatment of venous thrombosis associated with Behcet’s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation , 2008, Clinical Rheumatology.

[158]  S. Yurdakul,et al.  A cost analysis of Behcet's syndrome in Turkey. , 2006, Rheumatology.

[159]  P. Mahadevan,et al.  An overview , 2007, Journal of Biosciences.

[160]  H. Kwon,et al.  Surgical outcomes and risk factors for postoperative complications in patients with Behcet’s disease , 2007, Clinical Rheumatology.

[161]  S. Akar,et al.  Circulated Activated Platelets and Increased Platelet Reactivity in Patients With Behçet’s Disease , 2006, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[162]  M. Nazıroğlu,et al.  Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease. , 2006, Annals of clinical and laboratory science.

[163]  F. España,et al.  Dyslipidaemia in Behçet’s disease as a thrombotic risk factor , 2006, Annals of the rheumatic diseases.

[164]  D. Corella,et al.  Thrombophilic risk factors and homocysteine levels in Behçet’s disease in eastern Spain and their association with thrombotic events , 2006, Thrombosis and Haemostasis.

[165]  S. Esmat,et al.  Lipoprotein (a) and nitrites in Behcet's disease: relationship with disease activity and vascular complications. , 2006, European journal of dermatology : EJD.

[166]  M. Can,et al.  Lipid peroxidation and homocysteine levels in Behçet's disease , 2006, Clinical chemistry and laboratory medicine.

[167]  N. Yenice,et al.  Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease , 2005, The British journal of dermatology.

[168]  Y. Turkoz,et al.  Serum Levels of Soluble P-Selectin Are Increased and Associated With Disease Activity in Patients With Behçet's Syndrome , 2005, Mediators of inflammation.

[169]  O. Uzun,et al.  Pulmonary vasculitis in behcet disease: a cumulative analysis. , 2005, Chest.

[170]  C. Beyan,et al.  Von Willebrand factor antigen levels in Behçet disease , 2005, American journal of hematology.

[171]  A. Kızıltunç,et al.  Levels of soluble E-selectin in patients with active Behçet’s disease , 2005, Clinical Rheumatology.

[172]  F. Numan,et al.  Pulmonary artery aneurysms in Behçet syndrome. , 2004, The American journal of medicine.

[173]  H. Yazıcı,et al.  Cerebral venous thrombosis is associated with major vessel disease in Behçet’s syndrome , 2004, Annals of the rheumatic diseases.

[174]  M. Ehrenfeld,et al.  Thrombophilic factors are not the leading cause of thrombosis in Behçet’s disease , 2004, Annals of the rheumatic diseases.

[175]  F. España,et al.  Activated protein C levels in Behçet's disease and risk of venous thrombosis , 2004, British journal of haematology.

[176]  A. Silman,et al.  Development of the BD-QoL: a quality of life measure specific to Behçet's disease. , 2004, The Journal of rheumatology.

[177]  H. Karabulut,et al.  Factor V Leiden and prothrombin gene G20210A mutations in ocular Behçet disease. , 2003, Acta ophthalmologica Scandinavica.

[178]  K. Dilek,et al.  Arterial lesions in Behçet's disease. , 2003, VASA. Zeitschrift fur Gefasskrankheiten.

[179]  K. Tanriverdi,et al.  Methylenetetrahydrofolate reductase gene C677T mutation and plasma homocysteine level in Behçet's disease , 2003, Rheumatology International.

[180]  N. Seyahi,et al.  The Long-Term Mortality and Morbidity of Behçet Syndrome: A 2-Decade Outcome Survey of 387 Patients Followed at a Dedicated Center , 2003, Medicine.

[181]  A. Tennant,et al.  The Behçet's disease activity index. , 2003, Advances in experimental medicine and biology.

[182]  O. Kim,et al.  Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions. , 2003, Thrombosis research.

[183]  Jong Wan Kim,et al.  The clinical features of Behcet's disease in Yongdong districts: analysis of a cohort followed from 1997 to 2001. , 2002, Journal of Korean medical science.

[184]  I. Fresko,et al.  Target organ associations in Turkish patients with Behçet's disease: a cross sectional study by exploratory factor analysis. , 2002, The Journal of rheumatology.

[185]  R. A. Najim,et al.  Dapsone in Behçet's Disease: A Double‐Blind, Placebo‐Controlled, Cross‐Over Study , 2002, The Journal of dermatology.

[186]  A. Orem,et al.  The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease. , 2002, Clinical biochemistry.

[187]  Sang-Woon Choi,et al.  Coagulation parameters and plasma total homocysteine levels in Behcet's disease. , 2002, Thrombosis research.

[188]  G. Espinosa,et al.  Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. , 2002, The American journal of medicine.

[189]  G. Polat,et al.  Association of the platelet glycoprotein Ia C807T/G873A gene polymorphism and thrombosis in Behçet patients. , 2002, Haematologia.

[190]  M. Akarsu,et al.  Increased levels of tissue factor pathway inhibitor may reflect disease activity and play a role in thrombotic tendency in Behçet's disease , 2001, American journal of hematology.

[191]  T. Ergun,et al.  Neutrophil activation in Behçet's disease. , 2001, Clinical and experimental rheumatology.

[192]  E. Tasali,et al.  Pulmonary manifestations of Behçet's disease , 2001, Thorax.

[193]  A. Denman,et al.  Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. , 2001, Rheumatology.

[194]  S. Yurdakul,et al.  Anticardiolipin antibodies in Behçet's disease: a reassessment. , 2001, Rheumatology.

[195]  G. Kural,et al.  Lipoprotein (a) in Behçet's Disease as an Indicator of Disease Activity and in Thrombotic Complications , 2001, European journal of ophthalmology.

[196]  E. Tasali,et al.  Pulmonary manifestations of Behçet's disease. , 2001, Thorax.

[197]  A. Elhan,et al.  Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease. , 2000, The Journal of rheumatology.

[198]  L. Tokgözoğlu,et al.  Hyperhomocysteinaemia and activated protein C resistance in Behçet’s disease , 2000, Journal of internal medicine.

[199]  N. Mogulkoc,et al.  Intracardiac thrombus in Behçet's disease: a systematic review. , 2000, Chest.

[200]  A. Siegbahn,et al.  Haemostasis in patients with Behçet's disease. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[201]  Nishikimi,et al.  Neutrophil and endothelial cell activation in the vasa vasorum in vasculo‐Behçet disease , 2000, Histopathology.

[202]  T. Tekinay,et al.  Procoagulant mutations and venous thrombosis in Behçet's disease. , 1999, Rheumatology.

[203]  I. Lavi,et al.  Thrombophilic factors and their relation to thromboembolic and other clinical manifestations in Behçet's disease. , 1999, The Journal of rheumatology.

[204]  R. Vaughan,et al.  Factor V Leiden mutation is associated with ocular involvement in Behçet disease. , 1999, American journal of ophthalmology.

[205]  O. Değer,et al.  Autoantibodies against Oxidatively Modified Low-Density Lipoprotein in Patients with Behçet’s Disease , 1999, Dermatology.

[206]  A. Ferrante,et al.  Enhancement of endothelial cell E-selectin expression by sera from patients with active Behçet's disease: moderate correlation with anti-endothelial cell antibodies and serum myeloperoxidase levels. , 1999, Clinical immunology.

[207]  M. Nalçacı,et al.  Antithrombin III, Protein C and Protein S Plasma Levels in Patients with Behçet's Disease , 1998, The Journal of international medical research.

[208]  N. Allı,et al.  Protein C and protein S activities in Behçet's disease as risk factors of thrombosis. , 1998, International journal of dermatology.

[209]  Ş. Kirazlı,et al.  Activated protein C resistance in Behçet's disease , 1998, Rheumatology International.

[210]  O. Değer,et al.  Relationship between lipid peroxidation and disease activity in patients with Behçet's disease. , 1997, Journal of dermatological science.

[211]  K. Dellagi,et al.  Protein S deficiency and antibodies to protein S in patients with Behçet's disease. , 1997, Thrombosis research.

[212]  S. Yurdakul,et al.  Management of aneurysms in Behçet's syndrome: an analysis of 24 patients. , 1997, Surgery.

[213]  M. Inanç,et al.  Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease. , 1996, British journal of rheumatology.

[214]  Ş. Kirazlı,et al.  Impaired haemostatic kinetics and endothelial function in Behçet's disease , 1996, Journal of internal medicine.

[215]  O. Ozcebe,et al.  Haemostatic markers of procoagulant imbalance in Behçet's disease , 1996, European journal of haematology.

[216]  A. Gürler,et al.  Evaluation of peripheral vascular system disorders in vascular symptom--free Behçet's disease. , 1996, Cardiovascular surgery.

[217]  H. Direskeneli,et al.  Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. , 1996, Annals of the rheumatic diseases.

[218]  B. Wechsler,et al.  Arterial lesions in Behçet's disease. A study in 25 patients. , 1995, The Journal of rheumatology.

[219]  A. Gürler,et al.  Plasma von Willebrand factor, tissue plasminogen activator, plasminogen activator inhibitor, and antithrombin III levels in Behçet's disease. , 1995, Scandinavian journal of rheumatology.

[220]  Y. Berkmen,et al.  Thoracic involvement in Behçet's disease: pathologic, clinical, and imaging features. , 1995, AJR. American journal of roentgenology.

[221]  G. Dudbridge.  A contemporary view , 1995 .

[222]  A. Bradbury,et al.  Surgical aspects of Behçet's disease , 1994, The British journal of surgery.

[223]  F. Numan,et al.  Pulmonary arterial aneurysms in Behçet's syndrome: a report of 24 cases. , 1994, British journal of rheumatology.

[224]  D. Menon,et al.  Coagulation and Fibrinolytic Activity in Behçet's Disease , 1991, Thrombosis and Haemostasis.

[225]  J. Sadler,et al.  Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms. , 1991, Blood.

[226]  R. Powell,et al.  Defective fibrinolysis in Behçet's syndrome: significance and possible mechanisms. , 1989, Annals of the rheumatic diseases.

[227]  R. Rosenberg,et al.  Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells , 1988, Molecular and cellular biology.

[228]  D. Betteridge,et al.  Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome , 1988, European journal of clinical investigation.

[229]  A. Markel,et al.  PLATELET FUNCTION IN BEHÇET'S DISEASE , 1984, The Journal of dermatology.

[230]  K. Johnson.  An Update. , 1984, Journal of food protection.

[231]  J. Oppenheimer,et al.  A Reassessment , 1979 .

[232]  R. Walsa.  [The syndrome]. , 1975, Orvosi hetilap.